Skip to Content

Notice

Bulk Manufacturer of Controlled Substances Application: Rhodes Technologies

This document has a comment period that ends in 52 days. (01/13/2020) Submit a formal comment

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 13, 2020.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on August 16, 2019, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Controlled substanceDrug codeSchedule
Marihuana7360I
Tetrahydrocannabinols7370I
Dihydromorphine9145I
Methylphenidate1724II
Codeine9050II
Dihydrocodeine9120II
Oxycodone9143II
Hydromorphone9150II
Hydrocodone9193II
Levorphanol9220II
Morphine9300II
Oripavine9330II
Thebaine9333II
Oxymorphone9652II
Noroxymorphone9668II
Tapentadol9780II
Fentanyl9801II

The company plans to manufacture the listed controlled substances in bulk for conversion and sale to finished dosage form manufacturers. In reference to drug codes 7360 (marihuana), and 7370 (tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic cannabidiol (CBD) and tetrahydrocannabinol (THC). No other activities for drug codes 7360 and 7370 are authorized for this registration.

Start Signature

Dated: October 30, 2019.

William T. McDermott,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2019-24545 Filed 11-8-19; 8:45 am]

BILLING CODE 4410-09-P